School of Biomedical and Health Sciences Victoria University Australia
Dass obtained his B App Sci (Hons) and PhD from Charles Sturt University, Australia. He has 22 years of basic and applied research in cancer. He has worked on bigpharma projects (Amgen, Novartis, Glaxo-Wellcome, Johnson & Johnson). He has published in Nature Medicine, Journal of the National Cancer Institute, Journal of Controlled Release and Biomaterials.
Metabolomics:Open Access received 895 citations as per Google Scholar report